130 related articles for article (PubMed ID: 20953255)
1. Correspondence (letter to the editor): Wholesale accusations?
Throm S
Dtsch Arztebl Int; 2010 Sep; 107(38):669; author reply 673-4. PubMed ID: 20953255
[No Abstract] [Full Text] [Related]
2. Correspondence (letter to the editor): Need for advice.
Grass G; Mäder K
Dtsch Arztebl Int; 2010 Sep; 107(38):672; author reply 673-4. PubMed ID: 20953261
[No Abstract] [Full Text] [Related]
3. Correspondence (letter to the editor): Trend gives cause for concern.
Maier C; Zenz M
Dtsch Arztebl Int; 2010 Sep; 107(38):670-1; author reply 673-4. PubMed ID: 20953257
[No Abstract] [Full Text] [Related]
4. Correspondence (letter to the editor): Opinion leaders.
Sachtleben S
Dtsch Arztebl Int; 2010 Sep; 107(38):669-70; author reply 673-4. PubMed ID: 20953256
[No Abstract] [Full Text] [Related]
5. Research dishonesty and conflict of interest.
Frizelle F
N Z Med J; 2002 Dec; 115(1167):U270. PubMed ID: 12552259
[No Abstract] [Full Text] [Related]
6. Correspondence (letter to the editor): Notorious weaknesses.
Maares J
Dtsch Arztebl Int; 2010 Sep; 107(38):670; author reply 673-4. PubMed ID: 20953258
[No Abstract] [Full Text] [Related]
7. Yes, industry influence is excessive.
Shah AA; Finucane TE
Int Psychogeriatr; 2007 Dec; 19(6):1004-10; discussion 1014-20. PubMed ID: 17711608
[No Abstract] [Full Text] [Related]
8. Drug research: marketing before evidence, sales before safety.
Klemperer D
Dtsch Arztebl Int; 2010 Apr; 107(16):277-8. PubMed ID: 20467552
[No Abstract] [Full Text] [Related]
9. Biomedical industrial sponsorship and its impact on the medical literature.
Morris PJ
World J Surg; 2006 Aug; 30(8):1371-3. PubMed ID: 16773249
[No Abstract] [Full Text] [Related]
10. [Clinical trials, pharmaceutical companies and clinical practice].
Peralta V
An Sist Sanit Navar; 2005; 28(1):7-16. PubMed ID: 15827575
[No Abstract] [Full Text] [Related]
11. Research funding, conflicts of interest, and the meta-methodology of public relations.
Rampton S; Stauber J
Public Health Rep; 2002; 117(4):331-9. PubMed ID: 12477914
[No Abstract] [Full Text] [Related]
12. Correspondence (letter to the editor): Search bias.
Braschoss A
Dtsch Arztebl Int; 2010 Sep; 107(38):671-2; author reply 673-4. PubMed ID: 20953260
[No Abstract] [Full Text] [Related]
13. The impact of selective publication on clinical research in pain.
Rowbotham MC
Pain; 2008 Dec; 140(3):401-404. PubMed ID: 19004556
[No Abstract] [Full Text] [Related]
14. Note from the editor.
Freedman R
Am J Psychiatry; 2010 Nov; 167(11):1407. PubMed ID: 21041255
[No Abstract] [Full Text] [Related]
15. Drug companies and publishers set out 10 steps to enhance credibility of industry sponsored trials.
Roehr B
BMJ; 2012 May; 344():e3767. PubMed ID: 22641830
[No Abstract] [Full Text] [Related]
16. Is the influence of the pharmaceutical industry on prescribing, research and publication in the field of psychogeriatrics excessive? - No.
Bhattacharyya S; Burns A
Int Psychogeriatr; 2007 Dec; 19(6):1010-4; discussion 1014-20. PubMed ID: 17711609
[No Abstract] [Full Text] [Related]
17. Bioethics, the Surviving Sepsis Campaign and the industry.
Bion J; Vincent JL; Angood P
Wien Klin Wochenschr; 2006 Feb; 118(1-2):63. PubMed ID: 16489529
[No Abstract] [Full Text] [Related]
18. Bioethics, the Surviving Sepsis Campaign, and the industry.
Wiedermann CJ
Wien Klin Wochenschr; 2005 Jul; 117(13-14):442-4. PubMed ID: 16091869
[No Abstract] [Full Text] [Related]
19. Conflicted medical journals and the failure of trust.
Jureidini JN; McHenry LB
Account Res; 2011 Jan; 18(1):45-54. PubMed ID: 21287414
[TBL] [Abstract][Full Text] [Related]
20. Re: Bioethics, the Surviving Sepsis Campaign, and the industry.
Röggla G; Moser B
Wien Klin Wochenschr; 2006 Feb; 118(1-2):65. PubMed ID: 16612881
[No Abstract] [Full Text] [Related]
[Next] [New Search]
